News
The method that can save lives
In yesterday’s edition of the largest newspaper in Norway, VG, the editorial team highlighted the importance of taking atrial
Advancing Arrhythmia Diagnostics: Insights from the Medical University of Lodz
At the International Congress on Electrocardiology 2025 (ISHNE & ISE) in Thessaloniki, Greece, experiences with the use of ECG247 at
We strengthen the ECG247 team with Tom Erik Dybhavn as Head of International Business Development
We are pleased to welcome Tom Erik Dybhavn as Head of International Business Development at ECG247. Tom Erik has extensive
CardioAlex 25, Alexandria, Egypt
ECG247 at the CardioAlex congress together with our Egyptian distributor, EGMED. The event provided an excellent opportunity to present our
New functionality in ECG247 web portal: Print og save ECG
It is now possible to print or save a single ECG strip directly from the ECG247 portal. This new feature
The NORSCREEN study has reached its goal of 50,000 participants!
The world's largest atrial fibrillation study with continuous long-term ECG recording, NORSCREEN (norscreen.org), has now included 50,000 participants. The purpose
ECG247 launches in Sweden
ECG247 is launched in Sweden together with our new distributor Cardiolex AB! Cardiolex is Sweden's largest distributor of ECG systems
Meet us at ESOC 25 in Helsinki!
Unrecognized atrial fibrillation is a frequent cause of stroke. With ECG247, you can screen for atrial fibrillation both before and
Edit the PDF report
The summary provides a quick overview of the automatic interpretation of arrhythmias. Occasionally, it may be necessary to adjust the
German AMEDTEC and ECG247 are joining forces
ECG247 begins collaborating with AMEDTEC in Germany. AMEDTEC focuses on cardio-pulmonary data management systems and provides integrated solutions via its
PhD in ECG247
The usefulness of ECG247 has been further confirmed through a medical doctorate at the University of Oslo. Doctor at the
Strengthening cybersecurity – support from the EU and the Research Council of Norway
ECG247 was awarded financial support from the EU and the Research Council of Norway this week to further strengthen the
Join our team as an international business developer!
Due to growing demand for ECG247 from hospitals and clinics in Norway and internationally, we are expanding our team. Our
Screening for atrial fibrillation: insights from the Norwegian Atrial Fibrillation Self-Screening Pilot Study
Cand.med. Edvard Liljedahl Sandberg at Institute of Clinical Medicine will be defending the thesis “Screening for atrial fibrillation: insights from
Updated scoring tool CHA2DS2-VA
To assess the risk of stroke in patients with atrial fibrillation, doctors around the world use a scoring system. Being
New functionality: Import patient list
For hospitals and research projects with many patients, the entire patient list can now be imported directly into the ECG247
News in the ECG247 portal
We have launched several new features in the ECG247 portal. The patient list now shows the results of the last
ECG247 in the Tromsø study
The Tromsø Study, initiated in 1974 in response to the high cardiovascular disease mortality rates in Northern Norway, has since
New trial published: ECG247 is highly suitable for evaluating heart rhythm disorders in athletes
Researchers from Bærum Hospital and St. Olavs Hospital, in collaboration with colleagues from Belgium and Australia, conducted a comparative study
Updated ECG247 app with QR code scanner
A new version of the ECG247 app has been launched. The update includes several improvements. An integrated QR code scanner
NTNU HUNT research centre has chosen ECG247
ECG247 has been awarded a contract by NTNU following a tendering process. ECG247 will deliver sensors and software during 2025-2026
International Medical Center, Cairo, Egypt
ECG247 has conducted the first training for a customer in Cairo, Egypt. The International Medical Center (IMC) in Cairo will
NORSCREEN design article published in EP Europace
The world's largest self-screening study for atrial fibrillation with continuous ECG uses ECG247. The study will include 35,000 participants from
20 000 participants in the NORSCREEN-trial
The NORSCREEN study is a national screening investigation for atrial fibrillation in people ≥65 years of age. The study is
ECG247 in Bandar Seri Begawan, Brunei
The Chua & Arif Specialist Clinic in Bandar Seri Begawan in Brunei uses the ECG247 on its patients. “It is
